bpv Legal/Tschechien advises on regulatory aspects in the largest acquisition ever in Czech and Slovak healthcare sector

17 February, 2017.  bpv BRAUN PARTNERS has advised Unilabs, a leading provider of clinical laboratory testing in Europe, controlled by APAX Partners LLP, in the successful acquisition of laboratories in Czech Republic and Slovakia, from Alpha Medical Group (in the Czech Republic: Aeskulap), the No. 1 provider of laboratory diagnostics in Eastern Europe.
In this acquisition, bpv BRAUN PARTNERS advised its client and performed due diligence on regulatory issues regarding the acquisition of Czech and Slovak laboratories, including environmental and compliance matters.
The bpv BRAUN PARTNERS team was led by managing partner Arthur Braun and Slovak partner Igor Augustinič with senior associates Ondrej Poništiak and Monika Kardošová.
Arthur Braun concluded, “We are glad to help Unilabs with its international growth and successful market entry to the Czech and Slovak clinical laboratory market. With a value of several hundred million Euros, this is one of the largest transactions, both of private equity investors as well as in healthcare in the region since the financial crisis.”